Authors
Reham Khalaf-Nazzal
Imad Dweikat
Anwar Dudin
Mosab Maree
Maysa Alawneh
Rasha Doulani
Mohammad Qarareyyeh
Mohammad Qadi
Pages From
1
Pages To
8
ISSN
0387-7604
Journal Name
0387-7604
Volume
44
Issue
5
Keywords
Megalencephalic leukoencephalopathy with subcortical cysts, Megalencephalic leukoencephalopathy with subcortical cysts
Project
'Stories of Hope, Stories from Palestine' translational genomics project
Abstract

Background
Recessive forms of megalencephalic leukoencephalopathy with subcortical cysts (MLC, OMIM 604004) is a rare early-onset leukodystrophy that presents with macrocephaly, seizures, slowly progressive gross motor deterioration, and MRI evidence of diffuse symmetric white matter swelling and subcortical cysts in the anterior temporal and frontoparietal regions. Later in the disease course, significant spasticity and ataxia develop, which may be accompanied by intellectual deterioration. This disease is caused mostly by biallelic pathogenic variants in the MLC1 gene.
Methods
In this study, we analysed the clinical and molecular architecture of 6 individuals, belonging to 4 unrelated consanguineous Palestinian families, presenting with consistent MLC features. We sequenced the entire coding and flanking intronic regions of the MLC1 gene.
Results
In all recruited individuals, we detected one recurrent homozygous splice donor mutation NM_015166.4: c.423 + 1G A. All parents were heterozygous carriers. The mutation abolishes a highly conserved splice site in humans and other species. In silico splice predictors suggested the loss of a canonical splice donor site (CADD score 33.0. SpliceAI: 0.980). The c.423 + 1G A variant is rare; it was detected in only 4 heterozygous carriers in gnomAD.
Conclusion
In this study, we identified a recurrent MLC1 variant (c.423 + 1G A) as the cause of MLC among a group of Palestinian patients originating from a particular region of the country. Cost-effective studies should be performed to evaluate the implementation of carrier screening in adults originating from this region. Our findings have the potential to contribute to improved genetic diagnosis and carrier testing for individuals within this population and the wider community.